For seniors facing the uphill battle of weight loss, injections offer a groundbreaking and hopeful avenue. These medical interventions are becoming a game-changer, providing a ray of hope for improved health and mobility.
Relatedsearches
At their core, weight management injections leverage hormonal pathways to facilitate weight reduction. By simulating the effects of satiety hormones, these treatments significantly curb appetite, leading to a more manageable weight loss process. Seniors interested in this approach should seek medical advice to ensure compatibility with their health status and current medications.
There are various branded products from pharmaceutical companies with different active ingredients. Semaglutide (Ozempic and Wegovy), liraglutide (Saxenda) and tirzepatide (Mounjaro) are all active ingredients used in the treatment of overweight and obesity. They all belong to a class of drugs known as GLP-1 receptor agonists, with the exception of tirzepatide, which also has the properties of a GIP receptor agonist.
Contrary to some media reports and portrayal on social media platforms, the newer weight loss drugs are not designed for people who want to lose a few pounds quickly. They are prescription drugs specifically intended to assist in the treatment of severe overweight or obesity.
Treatment with weight loss injections is generally suitable for people who:
Have a body mass index (BMI) of 30 or higher (obesity).
Have a BMI of 27 or higher and also suffer from weight-related health problems such as type 2 diabetes, high blood pressure or dyslipidemia.
Have difficulty losing significant weight through diet and exercise alone.
Are willing to combine their lifestyle changes with drug treatment to achieve long-term results.
Although semaglutide, for example, is generally considered well tolerated, a careful weighing of benefits and potential risks is essential.
With proper treatment for obesity, 30 to 40 kilograms per year are possible, or current studies indicate 15-20% weight loss. In the STEP 1 study on semaglutide, obese non-diabetics taking semaglutide plus lifestyle intervention had lost around 14.9% of their weight after just over a year (BMI: -5.5 kg/m2), while the placebo group with lifestyle intervention alone, i.e. without GLP-1 medication, only managed around 2.4% (BMI: -0.9 kg/m2). 32% of the subjects in the semaglutide group even achieved a weight loss of over 20%, compared to just 1.7% in the placebo group. The recently published STEP-3 study showed that semaglutide is even more effective with a much more intensive diet and exercise program. Here, the weight loss was -16%.
Weight loss injections are often described as revolutionary because their ability to significantly reduce the feeling of hunger and thus reduce food intake without the patient having to constantly think about food represents a breakthrough in the treatment of overweight and obesity. These drugs offer many people a realistic hope of successful weight loss, especially when combined with a healthy diet and regular exercise.
Yes, it is possible to buy or get a prescription for weight loss injections such as Wegovy, Saxenda or Mounjaro online with a valid doctor's prescription. Online pharmacies and specialized medical service providers offer this service. At SoLean, you can request a prescription after a medical consultation (100% digital) and have the medication delivered directly to your home.
Relatedsearches